BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 38315896)

  • 1. Pathologic, cytogenetic, and molecular features of acute myeloid leukemia with megakaryocytic differentiation: A report from the Children's Oncology Group.
    Chisholm KM; Smith J; Heerema-McKenney AE; Choi JK; Ries RE; Hirsch BA; Raimondi SC; Wang YC; Dang A; Alonzo TA; Sung L; Aplenc R; Gamis AS; Meshinchi S; Kahwash SB
    Pediatr Blood Cancer; 2023 May; 70(5):e30251. PubMed ID: 36789545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital acute megakaryocytic leukemia.
    Mathur NB; Joshi N; Singh T; Singh M
    Indian J Med Paediatr Oncol; 2011 Jul; 32(3):165-7. PubMed ID: 22557786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the characteristics and prognostic impact of FUS::ERG and RUNX1::CBFA2T3 fusion genes in adult acute myeloid leukemia patients.
    Zhou Z; Zhuo N; Zhou Y; Sun C; Yao Y; Mao L; Zhang Y; Hong Q; Pan P; Tong H; Jin J; Wang H
    Am J Hematol; 2024 Apr; ():. PubMed ID: 38651500
    [No Abstract]   [Full Text] [Related]  

  • 4. CBFA2T3-GLIS2-positive acute myeloid leukaemia. A peculiar paediatric entity.
    Masetti R; Bertuccio SN; Pession A; Locatelli F
    Br J Haematol; 2019 Feb; 184(3):337-347. PubMed ID: 30592296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biology of pediatric acute megakaryoblastic leukemia.
    Gruber TA; Downing JR
    Blood; 2015 Aug; 126(8):943-9. PubMed ID: 26186939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Analysis of Pediatric Acute Megakaryocytic Leukemia With CBFA2T3-GLIS2 Fusion Gene.
    Du Y; Yang L; Qi S; Chen Z; Sun M; Wu M; Wu B; Tao F; Xiong H
    J Pediatr Hematol Oncol; 2024 Mar; 46(2):96-103. PubMed ID: 38315896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non-Down syndrome.
    Hara Y; Shiba N; Ohki K; Tabuchi K; Yamato G; Park MJ; Tomizawa D; Kinoshita A; Shimada A; Arakawa H; Saito AM; Kiyokawa N; Tawa A; Horibe K; Taga T; Adachi S; Taki T; Hayashi Y
    Genes Chromosomes Cancer; 2017 May; 56(5):394-404. PubMed ID: 28063190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic significance of chimeric fusion gene analysis in pediatric acute megakaryoblastic leukemia].
    Tamefusa K; Fukutake K; Ishida H; Tamura A; Endo M; Hamamoto K; Koga Y; Yamada M; Kanamitsu K; Fujiwara K; Washio K; Shimada A
    Rinsho Ketsueki; 2019; 60(2):99-105. PubMed ID: 30842387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Courses of Two Pediatric Patients with Acute Megakaryoblastic Leukemia Harboring the CBFA2T3-GLIS2 Fusion Gene.
    Ishibashi M; Yokosuka T; Yanagimachi MD; Iwasaki F; Tsujimoto SI; Sasaki K; Takeuchi M; Tanoshima R; Kato H; Kajiwara R; Tanaka F; Goto H; Yokota S
    Turk J Haematol; 2016 Dec; 33(4):331-334. PubMed ID: 27094503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hh/Gli antagonist in acute myeloid leukemia with CBFA2T3-GLIS2 fusion gene.
    Masetti R; Bertuccio SN; Astolfi A; Chiarini F; Lonetti A; Indio V; De Luca M; Bandini J; Serravalle S; Franzoni M; Pigazzi M; Martelli AM; Basso G; Locatelli F; Pession A
    J Hematol Oncol; 2017 Jan; 10(1):26. PubMed ID: 28109323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DHH-RHEBL1 fusion transcript: a novel recurrent feature in the new landscape of pediatric CBFA2T3-GLIS2-positive acute myeloid leukemia.
    Masetti R; Togni M; Astolfi A; Pigazzi M; Manara E; Indio V; Rizzari C; Rutella S; Basso G; Pession A; Locatelli F
    Oncotarget; 2013 Oct; 4(10):1712-20. PubMed ID: 24127550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CBFA2T3-GLIS2 model of pediatric acute megakaryoblastic leukemia identifies FOLR1 as a CAR T cell target.
    Le Q; Hadland B; Smith JL; Leonti A; Huang BJ; Ries R; Hylkema TA; Castro S; Tang TT; McKay CN; Perkins L; Pardo L; Sarthy J; Beckman AK; Williams R; Idemmili R; Furlan S; Ishida T; Call L; Srivastava S; Loeb AM; Milano F; Imren S; Morris SM; Pakiam F; Olson JM; Loken MR; Brodersen L; Riddell SR; Tarlock K; Bernstein ID; Loeb KR; Meshinchi S
    J Clin Invest; 2022 Nov; 132(22):. PubMed ID: 36136600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azacitidine and venetoclax for post-transplant relapse in a case of CBFA2T3/GLIS2 childhood acute myeloid leukaemia.
    Mishra AK; Mullanfiroze K; Chiesa R; Vora A
    Pediatr Blood Cancer; 2021 Nov; 68(11):e29221. PubMed ID: 34260140
    [No Abstract]   [Full Text] [Related]  

  • 14. CD56, HLA-DR, and CD45 recognize a subtype of childhood AML harboring CBFA2T3-GLIS2 fusion transcript.
    Zangrando A; Cavagnero F; Scarparo P; Varotto E; Francescato S; Tregnago C; Cuccurullo R; Fagioli F; Nigro LL; Masetti R; Putti MC; Rizzari C; Santoro N; Pession A; Pigazzi M; Locatelli F; Basso G; Buldini B
    Cytometry A; 2021 Aug; 99(8):844-850. PubMed ID: 33811445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Transcriptome Profiling of Cryptic
    Smith JL; Ries RE; Hylkema T; Alonzo TA; Gerbing RB; Santaguida MT; Eidenschink Brodersen L; Pardo L; Cummings CL; Loeb KR; Le Q; Imren S; Leonti AR; Gamis AS; Aplenc R; Kolb EA; Farrar JE; Triche TJ; Nguyen C; Meerzaman D; Loken MR; Oehler VG; Bolouri H; Meshinchi S
    Clin Cancer Res; 2020 Feb; 26(3):726-737. PubMed ID: 31719049
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.